SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing intense volatility and heavy retail debate following an earnings report that missed revenue and profit expectations, yet highlighted massive backlog growth to nearly two billion dollars. The community remains sharply divided between bulls citing the record backlog and long-term space sector potential, and bears highlighting persistent cash burn, dilution risks, and delays to key missions.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility as investors debate the impact of an accelerated lockup expiration, which has increased share supply and put downward pressure on the fund's premium to its net asset value (NAV). The community remains sharply divided, with bulls pointing to the fund's exposure to high-profile private AI and space companies as long-term catalysts, while bears warn that the stock remains overvalued compared to its underlying asset base.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors and community members speculate on a potential take-private bid from Nelson Peltz's Trian Fund Management, fueling expectations of a premium buyout offer. The stock's high short interest has retail traders aggressively discussing a possible short squeeze, as they debate the potential offer price and advocate for buying and holding shares to maintain pressure on short sellers.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson remains a focal point for investors as it balances robust quarterly performance and a strong oncology pipeline against ongoing legal risks from talc litigation. Community sentiment reflects a mix of confidence in its long-term healthcare leadership and defensive stability, alongside active speculation regarding its M&A strategy to secure dominance in the oncology space.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting significant community attention as investors pivot toward projects with tangible decentralized cloud infrastructure and AI-native utility. While the stock experiences volatility and skepticism regarding its historical performance, bulls are actively accumulating and staking in anticipation of ecosystem growth through AI-powered canister development and broader enterprise adoption.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is currently a focal point for investors due to its role in the emerging Physical AI and robotics sector, underscored by its recent record-breaking earnings and strategic expansion into smart infrastructure. The community is actively debating the company's long-term execution capabilities and the impact of its recent capital raise, with many weighing the stock's high-growth potential against the ongoing volatility typical of the lidar sector.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as community members closely watch its strategic U.S. Army partnership for critical mineral processing, with discussions heavily focused on the company's positioning ahead of upcoming regulatory deadlines for domestic supply chain independence. While some investors are accumulating shares, citing potential long-term growth and short squeeze dynamics, others are expressing concern over recent price volatility and the lack of immediate updates following the company's latest funding round.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing intense volatility as investors react to a significant follow-on order from a lead AI processor customer, while traders debate whether the stock's massive year-to-date rally and aggressive valuation are supported by fundamentals or inflated by pump-and-dump concerns. The community remains deeply divided, with some highlighting the company's monopoly-like position in reliability testing for AI chips, while others point to heavy insider selling and the potential for share dilution as red flags that could trigger a deeper correction.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock has found a durable bottom in the low $40s or if it remains a value trap amid ongoing concerns regarding China market share and competitive pressure. The community is heavily split, with many traders accumulating shares to capitalize on the attractive dividend yield and potential for a long-term turnaround, while vocal bears argue that the stock's multi-year downtrend and fundamental management issues point toward further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of +12.50% and +283.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership

GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company moves to end its collaboration with Alector.read more...

Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of +40.00% and -65.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know

Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alkermes (ALKS) Reports Q1 Loss, Beats Revenue Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of +30.31% and +9.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Alector, Inc. (NASDAQ:ALEC) Given Consensus Rating of "Hold" by Brokerages

Shares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have earned an average rating of "Hold" from the eight research firms that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issu...

Short Interest in Alector, Inc. (NASDAQ:ALEC) Drops By 18.0%

Alector, Inc. (NASDAQ:ALEC - Get Free Report) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totaling 5,151,723 shares, a...

This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.read more...

Cantor Fitzgerald Upgrades Alector (NASDAQ:ALEC) to "Overweight"

Cantor Fitzgerald upgraded Alector from a "neutral" rating to an "overweight" rating in a research report on Wednesday...

Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Analysts

Alector, Inc. (NASDAQ:ALEC - Get Free Report) has received a consensus rating of "Hold" from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a...

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Alector Inc

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.96
Prev Close	$2.04
Open	$2.04
Dividend Yield	0.00%
50-Day Moving Average	$1.69
Beta	1.77
Avg. Volume	497,597.07
PE Ratio	-1.79

52-Week High	$3.40
52-Week Low	$1.09
Market Capitalization	$227.78M
EPS (Annual)	-$1.39
Price to Book	-21.95
Revenue Per Employee	$204,320.39

Feed

News

Sentiment

Earnings

Fundamentals

Info